DIALYSIS · CCN 332621

DaVita Haven Dialysis

NEW YORK, NY 10032

DialysisProfitDaVita
$3.1M
TOTAL REVENUE
-37.1%
OPERATING MARGIN
5 / 5
STAR RATING
10
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$3.1M
Total costs
$4.2M
Operating income (rev − costs)
−$1.1M
Operating margin
-37.1%
Total charges
$2.9M
Total treatments
6,640
Dialysis stations
24

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

10 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.5336—
Five Star Rating
DFC_FIVE_STAR
5——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
2.4240—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
2——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
137.293—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
13.5510—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
43.929—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
19.435—
Standardized ED Visits Ratio
DFC_SEDR
0.6933—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
20.228—